D.C. Court Upholds FDA Classification Of CollaGenex' Periostat

D.C. federal judge agrees with FDA's argument that Periostat should be classified as an antibiotic since it contains the drug doxycycline, which was previously classified as an antibiotic. CollaGenex is seeking a separate injunction to prevent Ivax and CorePharma from marketing generic versions of the periodontal agent.